{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:56:27Z","timestamp":1768622187407,"version":"3.49.0"},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.2169\/internalmedicine.8395-21","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T22:14:14Z","timestamp":1636150454000},"page":"1713-1719","source":"Crossref","is-referenced-by-count":3,"title":["Trisomy 8-positive Polycythemia Vera Complicated with Intestinal Beh\u00e7et's-like Disease: A New Perspective for a Clinical Approach"],"prefix":"10.2169","volume":"61","author":[{"given":"Yuki","family":"Mori","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kuno","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Takano","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Kirito","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Enomoto","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. James DG. Beh\u00e7et&apos;s syndrome. N Engl J Med 301: 431-432, 1979.","DOI":"10.1056\/NEJM197908233010811"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Beh\u00e7et&apos;s disease. Semin Arthritis Rheum 27: 197-217, 1998.","DOI":"10.1016\/S0049-0172(98)80001-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sakane T, Takeno M, Suzuki N, Inaba G. Beh\u00e7et&apos;s disease. N Engl J Med 341: 1284-1291, 1999.","DOI":"10.1056\/NEJM199910213411707"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dil\u015fn N, Koni\u00e7e M, Aral O, Ocal L, Inan\u00e7 M, G\u00fcl A. Comparative study of the skin pathergy test with blunt and sharp needles in Beh\u00e7et&apos;s disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 52: 823-825, 1993.","DOI":"10.1136\/ard.52.11.823"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bare\u0161i\u0107 M, Reihl M, Habek M, Vukojevi\u0107 N, Ani\u0107 B. Improvement of neurological and ocular symptoms of Beh\u00e7et&apos;s disease after the introduction of infliximab. Rheumatol Int 38: 1301-1306, 2018.","DOI":"10.1007\/s00296-018-4054-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Adachi Y, Tsutsumi A, Murata H, et al. Beh\u00e7et&apos;s disease accompanied by myelodysplastic syndrome with trisomy 8: two case reports and review of 15 Japanese cases. Mod Rheumatol 13: 90-94, 2003.","DOI":"10.3109\/s101650300015"},{"key":"7","unstructured":"7. Kaloterakis A, Stavrianeas NG, Karagianni IN, et al. Adamantiades-Beh\u00e7et&apos;s disease coexisting with acute myeloblastic leukaemia. Br J Dermatol 137: 317-318, 1997."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Narazaki T, Shiratsuchi M, Tsuda M, et al. Intestinal Beh\u00e7et&apos;s disease with primary myelofibrosis involving trisomy 8. Acta Haematol 142: 253-256, 2019.","DOI":"10.1159\/000501019"},{"key":"9","unstructured":"9. Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, Nagasawa K. The association of Beh\u00e7et&apos;s disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol 24 (Suppl 42): S115-S119, 2006."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kawabata H, Sawaki T, Kawanami T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med 45: 1309-1314, 2006.","DOI":"10.2169\/internalmedicine.45.1718"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Toyonaga T, Nakase H, Matsuura M, et al. Refractoriness of intestinal Beh\u00e7et&apos;s disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature. Digestion 88: 217-221, 2013.","DOI":"10.1159\/000355341"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chen G, Zeng W, Miyazato A, et al. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 104: 4210-4218, 2004.","DOI":"10.1182\/blood-2004-01-0103"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Spivak JL. How I treat polycythemia vera. Blood 134: 341-352, 2019.","DOI":"10.1182\/blood.2018834044"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mendez Luque LF, Blackmon AL, Ramanathan G, Fleischman AG. Key role of inflammation in myeloproliferative neoplasms: instigator of disease initiation, progression and symptoms. Curr Hematol Malig Rep 14: 145-153, 2019.","DOI":"10.1007\/s11899-019-00508-w"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Thomas P, Keightley A, Kamble R, Gunasekera N, Johnson MR. Sigmoid sinus thrombosis presenting with posterior alexia in a patient with Beh\u00e7et&apos;s disease and polycythaemia: a case report. J Med Case Rep 2: 175, 2008.","DOI":"10.1186\/1752-1947-2-175"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Adeeb F, Tayel M, El Kaffash DM, Idris KM, Hassan MF, Fraser AD. Janus kinase 2 V617F mutation and thrombotic events in Behcet&apos;s disease: the Alexandria experience. Eur J Rheumatol 3: 73-74, 2016.","DOI":"10.5152\/eurjrheum.2015.0067"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ar MC, Hatemi G, Ekizo\u011flu S, et al. <i>JAK2<\/i><sup>V617F<\/sup> mutation is not associated with thrombosis in Behcet syndrome. Clin Appl Thromb Hemost 18: 421-426, 2012.","DOI":"10.1177\/1076029611427440"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wang S, Broder N, Marchetta P, Nowatzky J. Myelodysplastic syndrome presenting as a Beh\u00e7et&apos;s-like disease with aortitis. BMJ Case Rep 2018: bcr2017220649, 2018.","DOI":"10.1136\/bcr-2017-220649"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Kristinsson SY, Landgren O, Samuelsson J, Bjorkholm M, Goldin LR. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95: 1216-1220, 2010.","DOI":"10.3324\/haematol.2009.020412"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736, 2008.","DOI":"10.1073\/pnas.0804812105"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut 66: 1039-1048, 2017.","DOI":"10.1136\/gutjnl-2015-310746"},{"key":"22","first-page":"416","volume":"48","author":"H Ogawa","year":"2001","unstructured":"22. Ogawa H, Kuroda T, Inada M, et al. Intestinal Beh\u00e7et&apos;s disease associated with myelodysplastic syndrome with chromosomal trisomy 8 - a report of two cases and a review of the literature. Hepatogastroenterology 48: 416-420, 2001.","journal-title":"Hepatogastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0172-6390","issn-type":"print"},{"key":"23","unstructured":"23. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn&apos;s disease. Nat Genet 40: 955-962, 2008."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ahn JK, Cha HS, Koh EM, et al. Behcet&apos;s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology 47: 1228-1230, 2008.","DOI":"10.1093\/rheumatology\/ken162"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Handa T, Nakatsue T, Baba M, Takada T, Nakata K, Ishii H. Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Beh\u00e7et&apos;s disease. Respir Investig 52: 75-79, 2014.","DOI":"10.1016\/j.resinv.2013.05.005"},{"key":"26","unstructured":"26. Handa T, Arai Y, Mitani K. Myelodysplastic syndrome associated with intestinal tract-type Beh\u00e7et disease characterized by an esophageal ulcer. Rinsho Ketsueki (Jpn J Clin Hematol) 45: 135-137, 2004 (in Japanese)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tsubata R, Suzuki F, Sugihara T, et al. An autopsy case of intestinal Beh\u00e7et&apos;s disease with sacroiliitis accompanied by myelodysplastic syndrome with trisomy 8. Nihon Rinsho Meneki Gakkai Kaishi (Jpn J Clin Immunol) 28: 48-55, 2005 (in Japanese).","DOI":"10.2177\/jsci.28.48"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis - Beh\u00e7et&apos;s syndrome. Leuk Lymphoma 42: 115-121, 2001.","DOI":"10.3109\/10428190109097683"},{"key":"29","first-page":"247","volume":"49","author":"Y Niwa","year":"1982","unstructured":"29. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Auto-oxidative damage in Beh\u00e7et&apos;s disease - endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49: 247-255, 1982.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yuki M, Fumihiko I, Yasuaki I, et al. Long-term outcome after surgery in a patient with intestinal Beh\u00e7et&apos;s disease complicated by myelodysplastic syndrome and trisomy 8. Intest Res 18: 469-475, 2020.","DOI":"10.5217\/ir.2019.09141"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Agrawal M, Kim ES, Colombel JF. JAK inhibitors safety in ulcerative colitis: practical implications. J Crohns Colitis 14 (Suppl 2): S755-S760, 2020.","DOI":"10.1093\/ecco-jcc\/jjaa017"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Beh\u00e7et&apos;s disease. Arch Ophthalmol 100: 1455-1458, 1982.","DOI":"10.1001\/archopht.1982.01030040433013"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, <i>IL10<\/i>, and <i>IL23R-IL12RB2<\/i> regions associated with Beh\u00e7ets disease. Nat Genet 42: 698-702, 2010.","DOI":"10.1038\/ng.625"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Fern\u00e1ndez-Clotet A, Castro-Poceiro J, Pan\u00e9s J. Tofacitinib for the treatment of ulcerative colitis. Expert Rev Clin Immunol 14: 11, 881-892, 2018.","DOI":"10.1080\/1744666X.2018.1532291"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/11\/61_8395-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T03:31:47Z","timestamp":1654313507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/11\/61_8395-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8395-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"8395-21"}}